Norne Securities initiates coverage of NattoPharma

Report this content

Oslo, Norway (27 November 2019)

Norne Securities has today re-initiated coverage of the NattoPharma share.

“We are pleased in the renewed interest in NattoPharma and hope this will further support shareholder value going forward. We are looking at a very strong end to the year and we are equally optimistic about the years to come”, says Kjetil Ramsøy, CEO in NattoPharma.

Please visit the company website for the report and more



For more information, please contact:

Kjetil Ramsøy

CEO NattoPharma

Email :

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.